Medicare’s Historic Prescription Drug Price Negotiations
JAMA · 2023
DOI: 10.1001/jama.2023.19506 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Lawrence O Gostin und 2 weiteren Autor:innen. Beteiligte Einrichtung: O'Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, DC. Hauptthemen laut MEDLINE: Drug Costs, Medicare, Prescription Drugs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
This Viewpoint evaluates the legal claims and policy implications of historic drug price negotiations possible with the Inflation Reduction Act of 2022.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- O'Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, DC.
- Center for Public Health Law and Policy, ASU Sandra Day O'Connor College of Law, Phoenix, Arizona.
Zitieren
APA
Gostin, L. O., Hodge, J. G., & Twinamatsiko, A. J. (2023). Medicare’s Historic Prescription Drug Price Negotiations. JAMA. https://doi.org/10.1001/jama.2023.19506
Vancouver
Gostin LO, Hodge JG, Twinamatsiko AJ. Medicare’s Historic Prescription Drug Price Negotiations. JAMA. 2023. doi:10.1001/jama.2023.19506
BibTeX
@article{Gostin2023,
author = {Gostin, Lawrence O and Hodge, James G and Twinamatsiko, Andrew J},
title = {Medicare’s Historic Prescription Drug Price Negotiations},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2023.19506}
}
EUVIMED